Cardinal Net Income From Continuing Ops from 2010 to 2026

CAH Stock  USD 211.23  0.84  0.40%   
Cardinal Health's Net Income From Continuing Ops is increasing with very volatile movements from year to year. Net Income From Continuing Ops is estimated to finish at about 1.5 B this year. For the period between 2010 and 2026, Cardinal Health, Net Income From Continuing Ops quarterly trend regression had median of  1,070,000,000 and r-value of  0. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2000-09-30
Previous Quarter
243 M
Current Value
454 M
Quarterly Volatility
618.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Cardinal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardinal Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 953.9 M, Interest Expense of 152.4 M or Selling General Administrative of 6.5 B, as well as many indicators such as Price To Sales Ratio of 0.24, Dividend Yield of 0.0038 or PTB Ratio of 1.53. Cardinal financial statements analysis is a perfect complement when working with Cardinal Health Valuation or Volatility modules.
  
Build AI portfolio with Cardinal Stock
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
The Net Income From Continuing Ops trend for Cardinal Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cardinal Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Cardinal Health's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Cardinal Health over the last few years. It is Cardinal Health's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardinal Health's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Very volatile
   Net Income From Continuing Ops   
       Timeline  

Cardinal Net Income From Continuing Ops Regression Statistics

Arithmetic Mean592,929,706
Coefficient Of Variation229.31
Mean Deviation907,479,792
Median1,070,000,000
Standard Deviation1,359,656,522
Sample Variance1848665.9T
Range5.8B
R-Value0
Mean Square Error1971904.8T
R-Squared0.00000279
Significance0.99
Slope449,363
Total Sum of Squares29578653.7T

Cardinal Net Income From Continuing Ops History

20261.5 B
20251.4 B
20241.6 B
2023853 M
2022262 M
2021-932 M
2020612 M

About Cardinal Health Financial Statements

Investors use fundamental indicators, such as Cardinal Health's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Cardinal Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Income From Continuing Ops1.4 B1.5 B

Currently Active Assets on Macroaxis

When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is there potential for Health Care Providers & Services market expansion? Will Cardinal introduce new products? Factors like these will boost the valuation of Cardinal Health. Projected growth potential of Cardinal fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.106
Dividend Share
2.033
Earnings Share
6.63
Revenue Per Share
977.31
Quarterly Revenue Growth
0.224
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cardinal Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardinal Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cardinal Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.